- Correction
- Open access
- Published:
Correction to: Bone‑targeted erythrocyte‑cancer hybrid membrane‑camouflaged nanoparticles for enhancing photothermal and hypoxia‑activated chemotherapy of bone invasion by OSCC
Journal of Nanobiotechnology volume 20, Article number: 2 (2022)
The Original Article was published on 26 October 2021
Correction to: J Nanobiotechnol (2021) 19:342 https://doi.org/10.1186/s12951-021-01088-9
Following publication of the original article [1], the authors identified an error in Fig. 8g. The correct figure is given in this erratum.
Original data:
Corrected Fig. 8:
Preliminary biosafety assay of Asp8[H40-TPZ/IR780@(RBC-H)] NPs. a The body weight change curves of nude mice bearing WSU-HN6 tumor after various treatment (n = 5, mean ± SD). b–d Main blood biochemical parameters of liver function including ALP, ALT, and AST. e, f Main biochemical parameters of kidney function including BUN and CRE. g H&E staining slices of major organs including heart, liver, spleen, lung, and kidney from each group. The mice without any therapy were as a blank group (scale bar = 50 μm). (A: Normal saline, B: Normal saline + Laser, C: TPZ + Laser, D: Asp8[H40-PEG@(RBC-H)] + Laser, E: H40-PEG loading IR780 + Laser, F: H40-TPZ/IR780@(RBC-H) + Laser, and G: Asp8[H40-TPZ/IR780@(RBC-H)] + Laser). ***p < 0.001
Furthermore, an error was identified in the Methods on Line 5 on page 23. The correct version is given in this erratum.
These cells were incubated for another 72 h.
“The authors apologise for this error”.
Reference
Chen H, Deng J, Yao X, He Y, Li H, Jian Z, Tang Yi, Zhang X, Zhang J, Dai H. Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC. J Nanobiotechnol. 2021;19:342.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Chen, H., Deng, J., Yao, X. et al. Correction to: Bone‑targeted erythrocyte‑cancer hybrid membrane‑camouflaged nanoparticles for enhancing photothermal and hypoxia‑activated chemotherapy of bone invasion by OSCC. J Nanobiotechnol 20, 2 (2022). https://doi.org/10.1186/s12951-021-01185-9
Published:
DOI: https://doi.org/10.1186/s12951-021-01185-9